dc.contributor.author
Mueller, Jana
dc.contributor.author
Schmidt, Daniel
dc.contributor.author
Kollan, Christian
dc.contributor.author
Lehmann, Marc
dc.contributor.author
Bremer, Viviane
dc.contributor.author
Zimmermann, Ruth
dc.date.accessioned
2018-06-08T10:32:36Z
dc.date.available
2017-11-21T11:04:29.593Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/20613
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-23914
dc.description.abstract
Background In Germany, medical care of prisoners is completely separated from
extramural health care. The extent and quality of medical care among prisoners
in Germany are therefore largely unknown. We performed a secondary data
analysis of pharmacy sales data for tuberculosis (TB), HIV, hepatitis C (HCV)
and opioid substitution treatment (OST) delivered to prisons in 11 federal
states (FS) in Germany between 01/2012 and 03/2013. The aims of this study
were to assess (i) the treatment availability for the selected diseases and
OST in German prisons, (ii) the proportion of prisoners treated per FS and
overall for TB, HIV, HCV and OST during the study period. Methods Substances
unique to or typically used for the treatment of each disease were defined as
marker substances with defined daily doses (DDD). For each marker substance we
assessed the cumulative number of DDD, the average daily number of DDD (DDDd)
and average treatment prevalence per day in percent (adTP). Accordingly, the
DDDd represents one person treated per day and the adTP means the proportion
of prisoners treated per day. We compared the adTP of the diseases with
previously measured prevalences. Results We obtained data from pharmacies
supplying prisons in 11 of 16 German FS. Of the included prisons, 41% were
supplied with medicines for TB, 71% for HIV and 58% for HCV and OST. Twice as
many delivered marker substances for TB were indicated for the continuation
phase and chemoprevention than the intensive phase. The HIV adTP ranged from
0.06% to 0.94%, HCV adTP ranged from 0.03% to 0.59% and OST adTP ranged from
0% to 7.90%. The overall adTP for the respective treatment was 0.39% for HIV,
0.12% for HCV and 2.18% for OST. Conclusions According to our findings
treatment rates for TB were consistent with the expected TB prevalence, at
least in Berlin. HIV treatment seems to be offered to an adequate proportion
of estimated infected prisoners. In contrast, the HCV treatment prevalence was
low. High variation among FS in provision of all treatments, particularly of
OST, point to inconsistent treatment practices, although nationwide extramural
treatment guidelines for Germany exist.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
Secondary data
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
High variability of TB, HIV, hepatitis C treatment and opioid substitution
therapy among prisoners in Germany
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
BMC Public Health. - 17 (2017), Artikel Nr. 843
dcterms.bibliographicCitation.doi
10.1186/s12889-017-4840-4
dcterms.bibliographicCitation.url
http://doi.org/10.1186/s12889-017-4840-4
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000028511
refubium.note.author
Der Artikel wurde in einer reinen Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000009135
dcterms.accessRights.openaire
open access